Abram Scientific is a novel diagnostic platform for diagnosis and characterization of coagulation-related disorders rapid hemostasis.
Abram Scientific has raised $11.8M in total funding. The most recent round was Series A. The last funding was announced in February 2026.
Abram Scientific is headquartered in Menlo Park, United States.
Abram Scientific is a novel diagnostic platform for diagnosis and characterization of coagulation-related disorders rapid hemostasis.
Abram Scientific is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Abram Scientific — Funding & Investors." VCBacked, February 25, 2026, https://www.vcbacked.co/company/abram-scientific. Accessed August 23, 2026.
VCBacked. (2026). Abram Scientific — Funding & Investors. Retrieved August 23, 2026, from https://www.vcbacked.co/company/abram-scientific
{{cite web |title=Abram Scientific — Funding & Investors |url=https://www.vcbacked.co/company/abram-scientific |website=VCBacked |access-date=August 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated